Skip to main content
main-content

Editor's pick

21-01-2021 | COVID-19 | News

No benefit of tocilizumab for people with severe COVID-19

Adding tocilizumab to standard care does not improve clinical outcomes for people with severe or critical COVID-19 and may increase mortality risk, according to findings from the TOCIBRAS trial published in The BMJ.

12-01-2021 | COVID-19 | Podcast | Article

Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine

Alfred Kim talks about the initial promise of hydroxychloroquine for COVID-19 and why it did not stand up to later scrutiny (13:06).

19-01-2021 | Patient-reported outcomes | News

Tender joints may not always signify active inflammatory arthritis

Among patients with longstanding rheumatoid arthritis or psoriatic arthritis, having tenderness in non-swollen joints is not significantly associated with the presence of active inflammation as measured by power Doppler ultrasound, researchers report.

Repurposing rheumatology drugs for COVID-19

Experts discuss the rationale, data on different agents, and the potential impact on rheumatology practice.

  • » Featuring insights from the COVID-19 Global Rheumatology Alliance, EULAR, and the Lupus Foundation of America

Latest from across the site

22-01-2021 | Comorbidities | News

‘Suboptimal metabolic control’ in people with arthritis, type 2 diabetes

Patients with rheumatoid arthritis or osteoarthritis and comorbid adult-onset type 2 diabetes have a clinical profile of severe diabetes with poor glycemic control, researchers report.

21-01-2021 | COVID-19 | News

No benefit of tocilizumab for people with severe COVID-19

Adding tocilizumab to standard care does not improve clinical outcomes for people with severe or critical COVID-19 and may increase mortality risk, according to findings from the TOCIBRAS trial published in The BMJ.

20-01-2021 | Rheumatoid arthritis | News

‘Excessive concerns’ about the safety of low-dose glucocorticoids

Rheumatologists and patients with rheumatoid arthritis have concerns about the safety of low-dose glucocorticoids that “greatly exceed” evidence from published data, researchers report.

19-01-2021 | Patient-reported outcomes | News

Tender joints may not always signify active inflammatory arthritis

Among patients with longstanding rheumatoid arthritis or psoriatic arthritis, having tenderness in non-swollen joints is not significantly associated with the presence of active inflammation as measured by power Doppler ultrasound, researchers report.

18-01-2021 | Lupus nephritis | News

FDA approves belimumab for lupus nephritis

Click through for more information on this announcement

18-01-2021 | Systemic lupus erythematosus | News

Factors predicting unsuccessful HCQ tapering, discontinuation identified in SLE patients

Canadian researchers have identified risk factors for poor outcomes in patients with systemic lupus erythematosus who taper or discontinue hydroxychloroquine treatment, including baseline prednisone use and age at diagnosis.

Telemedicine in rheumatology: COVID-19 & beyond

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Latest from us on Twitter

Trending this week

Image Credits